Insiders · CERE

CERE insider transactions

Cerevel Therapeutics Holdings Inc. (CERE) Form 4 insider transactions - real-time wire coverage of every officer, director, and 10% owner trade.

Recent Form 3, 4, and 5 filings for CERE

• 671d
  Former 10% Owner Pfizer Inc closing all direct ownership in the company (SEC Form 4)

  4 - Cerevel Therapeutics Holdings, Inc. (0001805387) (Issuer)
• 671d
  Director Bain Capital Investors Llc returned 65,679,781 shares to the company (SEC Form 4)

  4 - Cerevel Therapeutics Holdings, Inc. (0001805387) (Issuer)
• 671d
  Director Gordon Christopher R returned 65,693,524 shares to the company, closing all direct ownership in the company (SEC Form 4)

  4 - Cerevel Therapeutics Holdings, Inc. (0001805387) (Issuer)
• 671d
  Director Koppel Adam returned 65,693,524 shares to the company, closing all direct ownership in the company (SEC Form 4)

  4 - Cerevel Therapeutics Holdings, Inc. (0001805387) (Issuer)
• 671d
  Chief Medical Officer Sanchez Ramiro returned 14,673 shares to the company, closing all direct ownership in the company (SEC Form 4)

  4 - Cerevel Therapeutics Holdings, Inc. (0001805387) (Issuer)
• 671d
  Director Giordano Douglas E. returned 13,743 shares to the company, closing all direct ownership in the company (SEC Form 4)

  4 - Cerevel Therapeutics Holdings, Inc. (0001805387) (Issuer)
• 671d
  President & CEO Renaud Ronald C Jr returned 244,309 shares to the company, closing all direct ownership in the company (SEC Form 4)

  4 - Cerevel Therapeutics Holdings, Inc. (0001805387) (Issuer)
• 671d
  Director Mckernan Ruth returned 13,743 shares to the company, closing all direct ownership in the company (SEC Form 4)

  4 - Cerevel Therapeutics Holdings, Inc. (0001805387) (Issuer)
• 671d
  Chief Legal Officer Akamine Scott returned 7,527 shares to the company, closing all direct ownership in the company (SEC Form 4)

  4 - Cerevel Therapeutics Holdings, Inc. (0001805387) (Issuer)
• 671d
  Director Sulzberger Gabrielle returned 58,876 shares to the company, closing all direct ownership in the company (SEC Form 4)

  4 - Cerevel Therapeutics Holdings, Inc. (0001805387) (Issuer)
• 671d
  Chief Scientific Officer Renger John returned 6,370 shares to the company, closing all direct ownership in the company (SEC Form 4)

  4 - Cerevel Therapeutics Holdings, Inc. (0001805387) (Issuer)
• 671d
  Chief Human Resources Officer Dipietro Kenneth returned 25,042 shares to the company, closing all direct ownership in the company (SEC Form 4)

  4 - Cerevel Therapeutics Holdings, Inc. (0001805387) (Issuer)
• 671d
  Officer Tregoning Kathleen returned 10,666 shares to the company, closing all direct ownership in the company (SEC Form 4)

  4 - Cerevel Therapeutics Holdings, Inc. (0001805387) (Issuer)
• 671d
  Director Dekkers Marijn E returned 444,609 shares to the company, closing all direct ownership in the company (SEC Form 4)

  4 - Cerevel Therapeutics Holdings, Inc. (0001805387) (Issuer)
• 671d
  Chief Financial Officer Altschuller Susan returned 16,913 shares to the company, closing all direct ownership in the company (SEC Form 4)

  4 - Cerevel Therapeutics Holdings, Inc. (0001805387) (Issuer)
• 671d
  Director Riedel Norbert G returned 56,553 shares to the company, closing all direct ownership in the company (SEC Form 4)

  4 - Cerevel Therapeutics Holdings, Inc. (0001805387) (Issuer)
• 671d
  Officer Bodenrader Mark returned 17,724 shares to the company, closing all direct ownership in the company (SEC Form 4)

  4 - Cerevel Therapeutics Holdings, Inc. (0001805387) (Issuer)
• 671d
  Director Patrick Deval L returned 13,743 shares to the company, closing all direct ownership in the company (SEC Form 4)

  4 - Cerevel Therapeutics Holdings, Inc. (0001805387) (Issuer)
• 671d
  Director Coles N Anthony returned 25,928 shares to the company, closing all direct ownership in the company (SEC Form 4)

  4 - Cerevel Therapeutics Holdings, Inc. (0001805387) (Issuer)
• 671d
  Officer Burgess Paul D. returned 45,727 shares to the company, closing all direct ownership in the company (SEC Form 4)

  4 - Cerevel Therapeutics Holdings, Inc. (0001805387) (Issuer)
• 705d
  Director Coles N Anthony exercised 25,000 shares at a strike of $3.50 and sold $1,029,535 worth of shares (25,000 units at $41.18) (SEC Form 4)

  4 - Cerevel Therapeutics Holdings, Inc. (0001805387) (Issuer)
• 730d
  Gordon Christopher R was granted 10,461 shares, increasing direct ownership by 319% to 13,743 units (SEC Form 4)

  4 - Cerevel Therapeutics Holdings, Inc. (0001805387) (Issuer)
• 730d
  Koppel Adam was granted 10,461 shares, increasing direct ownership by 319% to 13,743 units (SEC Form 4)

  4 - Cerevel Therapeutics Holdings, Inc. (0001805387) (Issuer)
• 730d
  Coles N Anthony was granted 10,290 shares, increasing direct ownership by 66% to 25,928 units (SEC Form 4)

  4 - Cerevel Therapeutics Holdings, Inc. (0001805387) (Issuer)
• 730d
  Patrick Deval L was granted 10,461 shares, increasing direct ownership by 319% to 13,743 units (SEC Form 4)

  4 - Cerevel Therapeutics Holdings, Inc. (0001805387) (Issuer)
• 730d
  Dekkers Marijn E was granted 10,461 shares, increasing direct ownership by 33% to 42,283 units (SEC Form 4)

  4 - Cerevel Therapeutics Holdings, Inc. (0001805387) (Issuer)
• 730d
  Riedel Norbert G was granted 10,461 shares, increasing direct ownership by 23% to 56,553 units (SEC Form 4)

  4 - Cerevel Therapeutics Holdings, Inc. (0001805387) (Issuer)
• 730d
  Giordano Douglas E. was granted 10,461 shares, increasing direct ownership by 319% to 13,743 units (SEC Form 4)

  4 - Cerevel Therapeutics Holdings, Inc. (0001805387) (Issuer)
• 730d
  Sulzberger Gabrielle was granted 10,461 shares, increasing direct ownership by 22% to 58,876 units (SEC Form 4)

  4 - Cerevel Therapeutics Holdings, Inc. (0001805387) (Issuer)
• 730d
  Mckernan Ruth was granted 10,461 shares, increasing direct ownership by 319% to 13,743 units (SEC Form 4)

  4 - Cerevel Therapeutics Holdings, Inc. (0001805387) (Issuer)
• 733d
  Coles N Anthony exercised 50,000 shares at a strike of $3.50 and sold $2,030,520 worth of shares (50,000 units at $40.61) (SEC Form 4)

  4 - Cerevel Therapeutics Holdings, Inc. (0001805387) (Issuer)
• 754d
  Coles N Anthony exercised 50,000 shares at a strike of $3.50 and sold $2,105,125 worth of shares (50,000 units at $42.10) (SEC Form 4)

  4 - Cerevel Therapeutics Holdings, Inc. (0001805387) (Issuer)
• 795d
  Coles N Anthony exercised 50,000 shares at a strike of $3.50 and sold $2,116,640 worth of shares (50,000 units at $42.33) (SEC Form 4)

  4 - Cerevel Therapeutics Holdings, Inc. (0001805387) (Issuer)
• 823d
  Coles N Anthony exercised 50,000 shares at a strike of $3.50 and sold $2,050,550 worth of shares (50,000 units at $41.01) (SEC Form 4)

  4 - Cerevel Therapeutics Holdings, Inc. (0001805387) (Issuer)
• 825d
  Coles N Anthony exercised 50,000 shares at a strike of $3.50 and sold $2,057,890 worth of shares (50,000 units at $41.16) (SEC Form 4)

  4 - Cerevel Therapeutics Holdings, Inc. (0001805387) (Issuer)
• 837d
  Perceptive Advisors Llc gifted 170,317 shares (SEC Form 4)

  4 - Cerevel Therapeutics Holdings, Inc. (0001805387) (Issuer)
• 845d
  Sulzberger Gabrielle received a gift of 562 shares, increasing direct ownership by 1% to 48,415 units (SEC Form 5)

  5 - Cerevel Therapeutics Holdings, Inc. (0001805387) (Issuer)
• 850d
  Renger John converted options into 5,020 shares and sold $89,777 worth of shares (2,161 units at $41.54), increasing direct ownership by 81% to 6,370 units (SEC Form 4)

  4 - Cerevel Therapeutics Holdings, Inc. (0001805387) (Issuer)
• 850d
  Coles N Anthony converted options into 15,440 shares and sold $104,110 worth of shares (2,506 units at $41.54), increasing direct ownership by 478% to 15,638 units (SEC Form 4)

  4 - Cerevel Therapeutics Holdings, Inc. (0001805387) (Issuer)
• 866d
  SEC Form 4 filed by Altschuller Susan

  4 - Cerevel Therapeutics Holdings, Inc. (0001805387) (Issuer)
• 866d
  SEC Form 4 filed by Renger John

  4 - Cerevel Therapeutics Holdings, Inc. (0001805387) (Issuer)
• 866d
  SEC Form 4 filed by Tregoning Kathleen

  4 - Cerevel Therapeutics Holdings, Inc. (0001805387) (Issuer)
• 866d
  SEC Form 4 filed by Dipietro Kenneth

  4 - Cerevel Therapeutics Holdings, Inc. (0001805387) (Issuer)
• 866d
  SEC Form 4 filed by Bodenrader Mark

  4 - Cerevel Therapeutics Holdings, Inc. (0001805387) (Issuer)
• 866d
  SEC Form 4 filed by Burgess Paul D.

  4 - Cerevel Therapeutics Holdings, Inc. (0001805387) (Issuer)
• 866d
  SEC Form 4 filed by Sanchez Ramiro

  4 - Cerevel Therapeutics Holdings, Inc. (0001805387) (Issuer)
• 866d
  SEC Form 4 filed by Renaud Ronald C Jr

  4 - Cerevel Therapeutics Holdings, Inc. (0001805387) (Issuer)
• 866d
  SEC Form 4 filed by Akamine Scott

  4 - Cerevel Therapeutics Holdings, Inc. (0001805387) (Issuer)
• 885d
  Coles N Anthony exercised 50,000 shares at a strike of $3.50 and sold $2,111,815 worth of shares (50,000 units at $42.24) (SEC Form 4)

  4 - Cerevel Therapeutics Holdings, Inc. (0001805387) (Issuer)
• 892d
  Tregoning Kathleen exercised 3,150 shares at a strike of $10.05, increasing direct ownership by 42% to 10,666 units (SEC Form 4)

  4 - Cerevel Therapeutics Holdings, Inc. (0001805387) (Issuer)
• 892d
  Sanchez Ramiro exercised 10,000 shares at a strike of $3.50 and sold $424,700 worth of shares (10,000 units at $42.47) (SEC Form 4)

  4 - Cerevel Therapeutics Holdings, Inc. (0001805387) (Issuer)
• 893d
  Dipietro Kenneth exercised 8,000 shares at a strike of $3.50 and sold $331,608 worth of shares (8,000 units at $41.45) (SEC Form 4)

  4 - Cerevel Therapeutics Holdings, Inc. (0001805387) (Issuer)
• 899d
  Bodenrader Mark converted options into 19,284 shares and sold $326,788 worth of shares (7,889 units at $41.42), increasing direct ownership by 180% to 17,724 units (SEC Form 4)

  4 - Cerevel Therapeutics Holdings, Inc. (0001805387) (Issuer)
• 899d
  Burgess Paul D. converted options into 23,847 shares, increasing direct ownership by 109% to 45,727 units (SEC Form 4)

  4 - Cerevel Therapeutics Holdings, Inc. (0001805387) (Issuer)
• 899d
  Dipietro Kenneth converted options into 13,913 shares and sold $259,144 worth of shares (6,256 units at $41.42), increasing direct ownership by 45% to 24,663 units (SEC Form 4)

  4 - Cerevel Therapeutics Holdings, Inc. (0001805387) (Issuer)
• 899d
  Akamine Scott converted options into 13,796 shares and sold $292,945 worth of shares (7,072 units at $41.42), increasing direct ownership by 1,311% to 7,237 units (SEC Form 4)

  4 - Cerevel Therapeutics Holdings, Inc. (0001805387) (Issuer)
• 899d
  Renaud Ronald C Jr converted options into 160,452 shares (SEC Form 4)

  4 - Cerevel Therapeutics Holdings, Inc. (0001805387) (Issuer)
• 899d
  Sanchez Ramiro converted options into 24,825 shares and sold $420,528 worth of shares (10,152 units at $41.42) (SEC Form 4)

  4 - Cerevel Therapeutics Holdings, Inc. (0001805387) (Issuer)
• 899d
  Altschuller Susan converted options into 30,721 shares and sold $571,972 worth of shares (13,808 units at $41.42) (SEC Form 4)

  4 - Cerevel Therapeutics Holdings, Inc. (0001805387) (Issuer)
• 899d
  Tregoning Kathleen converted options into 13,804 shares and sold $260,469 worth of shares (6,288 units at $41.42) (SEC Form 4)

  4 - Cerevel Therapeutics Holdings, Inc. (0001805387) (Issuer)